Logo - P&S Intelligence
  • Home
  • Report Store
    • Report Store
      • Consumer Products
      • Life Sciences
      • ICT and Media
      • Semiconductor and Electronics
      • Chemicals and Materials
      • Automotive and Transportation
      • Power and Energy
    • Back
  • Services
  • Knowledge Center
    • Knowledge Center
      • Press Journals
      • Blogs
    • Back
  • About Us
  • Contact Us
  • Home
  • Order Summary & Billing Information
Order Summary
Radioligand Therapy Market Size & Share Analysis by Indication (Prostate Cancer, Neuroendocrine Tumors), Drug (Lutathera, Pluvicto, Xtandi, Xofigo, Zytiga), End-User (Hospitals, Clinics, Academic and Research Institutes), Distribution Channel (Direct, Indirect) - Forecast to 2030
License Type
Single User License
Price
USD 4900
Total amount to be paid
USD 4900
Price
₹ 3,96,900
GST @ 18%
₹ 71,442
Total amount to be paid
₹ 4,68,342
Billing Information
Select a payment mode
  • Secure Payment
  • Secured by PayPal
Clicking Proceed to Secure Checkout means that you agree to the P&S Intelligence's terms & conditions

Connect with us
Quick Links
  • Research Methodology
  • Career
  • Media Citations
  • FAQs
Find Help
  • How to Order
  • Privacy Policy
  • Terms & Conditions
  • Sitemap
24/7 Customer Support
  • International: +1-347-960-6455
  • US/Canada Toll Free: +1-888-778-7886
  • India: +91-120-454-1337
  • For business enquiries - [email protected]
  • For career enquiries - [email protected]
  • Dun-Verified
  • Paypal-Secure

©2023 P&S Intelligence. All Rights Reserved.

We use cookies to enhance your experience. By continuing to use this site you consent to our use of cookies. Privacy Policy X